| Balmore W Williams, MD | |
|
202 N Washington Ave, Cleveland, TX 77327 | |
| (281) 592-2656 | |
| (281) 592-9723 |
| Full Name | Balmore W Williams |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 202 N Washington Ave, Cleveland, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932103629 | NPI | - | NPPES |
| 144323602 | Medicaid | TX | |
| 8143693 | Other | TX | CIGNA |
| 7486286 | Other | TX | AETNA |
| 8B9860 | Other | TX | BCBS PROVIDER NUMBER |
| 144323601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L2751 (Texas) | Primary |
| Entity Name | Williams Family Practice Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881898922 PECOS PAC ID: 0648330589 Enrollment ID: O20081121000201 |
News Archive
A lacquer containing resin from the Norway spruce shows promise as a treatment for onychomycosis, suggest results from an exploratory study.
Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has priced a public offering of 10,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase one share of common stock, at a purchase price of $2.25 per unit for an aggregate offering amount of $22.5 million.
In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.
› Verified 6 days ago
| Entity Name | Texienne Oncology Centers, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700017449 PECOS PAC ID: 7012054281 Enrollment ID: O20091020000492 |
News Archive
A lacquer containing resin from the Norway spruce shows promise as a treatment for onychomycosis, suggest results from an exploratory study.
Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has priced a public offering of 10,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase one share of common stock, at a purchase price of $2.25 per unit for an aggregate offering amount of $22.5 million.
In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Balmore W Williams, MD 202 N Washington Ave, Cleveland, TX 77327 Ph: (281) 592-2656 | Balmore W Williams, MD 202 N Washington Ave, Cleveland, TX 77327 Ph: (281) 592-2656 |
News Archive
A lacquer containing resin from the Norway spruce shows promise as a treatment for onychomycosis, suggest results from an exploratory study.
Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.
The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that it has priced a public offering of 10,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase one share of common stock, at a purchase price of $2.25 per unit for an aggregate offering amount of $22.5 million.
In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.
› Verified 6 days ago
George Nicholas Stokes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 E Boothe, Ste 100, Cleveland, TX 77327 Phone: 281-592-2888 Fax: 281-592-2835 | |
Dr. Jasmine Sulaiman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 207 East Crockett, Cleveland, TX 77327 Phone: 281-592-2224 Fax: 281-592-2225 | |
Mr. Mark Kreit, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 N College Ave, Cleveland, TX 77327 Phone: 281-592-2426 Fax: 281-539-0060 | |
Dr. Duc Minh Le, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 E Houston St, Cleveland, TX 77327 Phone: 281-593-1500 Fax: 281-593-1509 | |
Camil I Kreit, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 403 E Dallas St, Cleveland, TX 77327 Phone: 281-659-9533 Fax: 281-659-9543 | |
Tamanna Ferdous, MD MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 307 N William Barnett Ave, Cleveland, TX 77327 Phone: 281-592-2224 | |
Ali Charif, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 E Crockett St, Cleveland, TX 77327 Phone: 281-592-5410 |